REN and neoplasm: Theoretically, neoangiogenesis is one of the key pathogenic mechanisms in hepatic cancer, and modulation of the renin-angiotensin-aldosterone system seems to be a possible anti-tumor mechanism of the anti-angiogenic and anti-fibrogenic activity of ARBs [31].